Cepazine
CAS No. 64544-07-6
Cepazine( Cefuroxime axetil | SN 407 | DRG-0157 | CXM-AX )
Catalog No. M15451 CAS No. 64544-07-6
Cefuroxime axetil is a second generation oral cephalosporin antibiotic. It was discovered by Glaxo now GlaxoSmithKline and introduced in 1987 as Zinnat.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 10MG | 32 | In Stock |
|
| 25MG | 68 | In Stock |
|
| 50MG | 115 | In Stock |
|
| 100MG | 178 | In Stock |
|
| 500MG | 462 | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameCepazine
-
NoteResearch use only, not for human use.
-
Brief DescriptionCefuroxime axetil is a second generation oral cephalosporin antibiotic. It was discovered by Glaxo now GlaxoSmithKline and introduced in 1987 as Zinnat.
-
DescriptionCefuroxime axetil is a second generation oral cephalosporin antibiotic. It was discovered by Glaxo now GlaxoSmithKline and introduced in 1987 as Zinnat.
-
In Vitro——
-
In Vivo——
-
SynonymsCefuroxime axetil | SN 407 | DRG-0157 | CXM-AX
-
PathwayOthers
-
TargetOther Targets
-
RecptorOthers
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number64544-07-6
-
Formula Weight510.47
-
Molecular FormulaC20H22N4O10S
-
Purity>98% (HPLC)
-
SolubilitySoluble in Water
-
SMILESO=C(C(N12)=C(COC(N)=O)CS[C@]2([H])[C@H](NC(/C(C3=CC=CO3)=N\OC)=O)C1=O)OC(OC(C)=O)C
-
Chemical Name5-Thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid, 3-(((aminocarbonyl)oxy)methyl)-7-((2-furanyl(methoxyimino)acetyl)amino)-8-oxo-, 1-(acetyloxy)ethyl ester, (6R-(6alpha,7beta(Z)))-
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Singh B, et al. Colloids Surf B Biointerfaces. 2014 Sep 1;121:92-8.
molnova catalog
related products
-
[Tyr8]-Atrial Natriu...
[Tyr8]-Atrial Natriuretic Peptide (5-27), rat; [Tyr8]-Atriopeptin II, rat
-
Isokurarinone
Isokurarinone is a natural product from Sophora flavescens Ait.
-
Crenulatin
Crenulatin has dual- direction effects on apoptosis of cerebral microvascular endothelial cells, inhibitive effect in 25 mg/L and stimulative effect in 100 mg/L group, respectively; the mechanism is related to the alterations of Fas/Bcl-2 expression and caspase-3 activity.
Cart
sales@molnova.com